Scientists are seen working at Cobra Biologics, they are working on a potential vaccine for COVID-19, following the outbreak of the coronavirus disease (COVID-19), in Keele, Britain, April 30, 2020.
After AstraZeneca on Monday became the latest drugmaker to say its vaccine offers high levels of protection from Covid-19, elderly citizens have high hopes of getting their jabs soon.
In the United Kingdom alone, there are 3.2 million people over 80, who will be among the first in line for a vaccine.
Only 40% of Americans say they will sign up for a first-generation vaccine, according to an index compiled by Axios and Ipsos.
Even if they’re willing, young and able-bodied people may have to wait until 2022 to be vaccinated, according to the WHO.
AstraZeneca, Axios, they’re
LONDON, Reuters, AstraZeneca, University of Oxford, Pfizer, Moderna, World Health Organization, WHO, JPMorgan
Keele, Britain, Covid, United Kingdom